Trials / Conditions / Neuroendocrine Carcinoma of Prostate
Neuroendocrine Carcinoma of Prostate
3 registered clinical trials studyying Neuroendocrine Carcinoma of Prostate — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate NCT06941480 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Recruiting | Efficacy and Safety Evaluation of Tarlatamab in Advanced Extrapulmonary Neuroendocrine Carcinoma Patients NCT06893783 | Inkeun Park | Phase 2 |
| Withdrawn | Regorafenib With Tislelizumab in Patients With Selected Mismatch Repair-Proficient/Microsatellite Stable Cance NCT05582031 | Translational Research in Oncology | Phase 2 |